NCT06243731View on ClinicalTrials.gov

A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation

Not yet recruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2027

Conditions
Cytomegalovirus (CMV)Kidney DiseaseKidney Failure
Interventions
OTHER

No Intervention

This is a non-interventional study.

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY